RE:RE:The listIncredible, zero follow through buying today, tells me one of 2 things, either the news was not good or there is nobody around to listen....a nice green day on the market and yet no love for Thera stock...was ready to average down but I'll wait for this news to be disseminated and our IR to get the story out...I have a non-scientific background but my layman's read is that this IS INDEED GOOD NEWS on the oncology side...go figure...the frustration continues for the retail base here...happy weekend all!
TH1902 wrote: Good post, the company imo has lost a lot of investors due to mgmt mis-steps in recent years. Could today's news be the start of something that brings investors back, we will see I suppose. Macro environment has also played a large role in where the sp currently resides. We need continued good news and a strong effort by IR to tell the story. Let's see if a deal comes to fruition soon, that would definitely bring interest. The Marathon deal is very, very meaningful, what do they know???
scarlet1967 wrote: Since THTX has been keeping their low profile as an investor loyal for over a decade I have been checking on various stuff on regular basis the list below and obviously the net.
Now my simple question is why does an investor has to go so far to gather information about their investment?
Yes one has to do the DD but isn't it the company's responsibility to keep their investors informed on regular basis so they know what the heck is going on?
How would they get much broader audience if their communication is limited to their own social media? Again today they gave us good news about the early results from the oncology trial which is significant as most of these patients have been treated well below the therapeutic window of the PDC yet despite all odds they have early signs of efficacy and a well tolerated dose so far. Even so Egrifta has been commercialized for a decade the sales are growing. They seem to have managed keeping costs down, secured additional financing deal, Trogarzo IV/IM trials are progressing well list and not last the NASH asset is ready to be initiated so how is that we get single digit appreciation from multi year low valuation? Am I missing something or is the company?
How can one solve a problem if they can't see it? How can you start making all the right moves if you think you already have? I think there are so many opportunities a head of this company but it seems the market doesn't!
Who is supposed to fix it? The journalists?